Test Price
5,000 AED✅ Home Collection Available
Glucose-6-Phosphate Dehydrogenase (G6PD) Full Length Gene Sequence Analysis in UAE – 5000 AED – DHA Licensed Molecular Genetics Diagnostics
Executive Summary & Core Metrics
Test Overview & Methodology
The G6PD full-length gene sequence analysis represents the most comprehensive molecular diagnostic approach for detecting pathogenic variants associated with Glucose-6-Phosphate Dehydrogenase deficiency. Using Sanger sequencing across every exon of the G6PD gene, this assay provides definitive molecular confirmation for lifelong hemolytic anemia risk assessment. The test is routinely recommended by geneticists, hematologists, and primary care physicians for at-risk individuals and family cascade screening.
| Feature | Our Test (G6PD Full Gene Sequence) | Closest Alternative (Enzyme Activity Assay) |
|---|---|---|
| Precision | Single‑nucleotide resolution – identifies exact mutation with 99.9% sensitivity | Quantitative enzyme level; may miss heterozygous females and recent transfusion cases |
| Method | Sanger Sequencing (gold standard molecular method) | Spectrophotometric enzyme activity assay |
| Turnaround | 2–3 weeks | 1–2 days |
| Clinical Impact | Lifetime molecular diagnosis enabling precise genetic counseling | Acute episode assessment only; false‑normal results possible during reticulocytosis |
Physician Insight & Safety Protocols
“The full-length G6PD gene sequence provides an unparalleled molecular roadmap for definitively diagnosing G6PD deficiency and identifying carrier status in at-risk family members. While the assay detects known pathogenic variants with exceptional precision, the clinical interpretation must always be correlated with the patient’s hemolytic episode history, enzyme activity levels, and trigger exposure profile. All results should be reviewed with your DHA‑licensed genetics specialist before implementing any changes to medication or dietary management.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Safety Advisory
Never adjust or discontinue prescribed medications without explicit guidance from your treating physician. While G6PD deficiency may necessitate avoiding certain oxidant drugs such as sulfonamides, dapsone, and primaquine, only a licensed clinician can safely evaluate your genetic results against your current therapeutic regimen. Self-directed medication changes can lead to serious adverse outcomes.
Clinical Exclusion Criteria & Emergency Indicators
- Exclusion: This genetic test is not recommended within 90 days of a blood transfusion, as donor leukocyte DNA may interfere with variant detection accuracy.
- Emergency Red Flags: Seek immediate emergency care if you experience sudden dark urine (cola-colored), scleral icterus, unexplained profound fatigue, or acute back pain following exposure to known triggers such as fava beans or specific medications.
Patient FAQ & Clinical Guidance
1. What is the G6PD full gene test and why is it necessary?
This molecular diagnostic test sequences the complete G6PD gene to identify inherited pathogenic variants that cause enzyme deficiency. Confirming the genetic basis enables precise risk assessment for hemolytic anemia and guides safe medication and dietary choices for both the patient and at-risk family members.
2. How is the sample collected, and can I arrange a home visit?
A standard peripheral whole blood sample is collected via routine venipuncture. VIP Mobile Phlebotomy with temperature-controlled cold-chain transport is available daily from 8 AM to 11 PM across Dubai and the Northern Emirates, ensuring specimen integrity from collection to laboratory processing.
3. What will the results tell me, and how long does the analysis take?
Results are delivered within 2–3 weeks and indicate whether a pathogenic G6PD variant is present. A negative sequencing result significantly reduces the likelihood of G6PD deficiency but does not completely exclude it if enzyme activity remains low due to non-genetic factors. Your genetics consultant will integrate molecular findings with clinical biochemistry for a comprehensive assessment.
4. Who should consider this genetic test?
Individuals with a family history of G6PD deficiency, unexplained hemolytic episodes, neonatal jaundice, or those of African, Mediterranean, or Southeast Asian descent are primary candidates. Prenatal testing using amniotic fluid or cord blood is also available for at-risk pregnancies under specialist guidance.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governing the secure processing of genetic and health information, and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields regulating digital health data exchange. All clinical genetic testing and patient consent procedures adhere to the standards outlined in Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory methodology is validated under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139). For insurance direct billing inquiries, contact WhatsApp +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | Glucose-6-Phosphate Dehydrogenase (G6PD) Full Length Gene Sequence Analysis |
| Price (AED) | 5,000 AED |
| Turnaround Time | 2–3 weeks |
| Sample Type / Matrix | Peripheral Whole Blood, Amniotic Fluid, or Cord Blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM) |
| Methodology Used | Sanger Sequencing (Full Gene, All Exons) |
| ICD-10-CM Code | D55.0, Z13.79 |
| LOINC Code | 21626-1 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians